Event Group
Event Groups are part of the Adverse Events Module within the Results Section. They provide a way to organize and summarize adverse event data by grouping related events together.
Each Event Group typically represents a category or class of adverse events and includes statistical information such as the number of participants affected and at risk for different event types: deaths, serious events, and other events.
Event Group path is as follows:
Study -> Results Section -> Adverse Events Module -> Event Group
Event Group
Ignite Creation Date:
2025-12-24 @ 9:47 PM
Ignite Modification Date:
2025-12-25 @ 7:26 PM
NCT ID:
NCT02551432
Group ID:
EG000
Title:
Paclitaxel Pembrolizumab
Description:
* PD-L1 Induction phase : Paclitaxel 175 mg/m2, Day 1 q 3weeks, intravenous,
* Post Induction treatment phase: Paclitaxel 175 mg/m2, Day 1 q 3weeks (maximum up to total 6 cycles) + pembrolizumab 200 mg D1 q 3 weeks, intravenous,
* Maintenance phase: pembrolizumab 200 mg D1 q 3 weeks, intravenous till PD or unacceptable toxicity
pembrolizumab, paclitaxel: pembrolizumab, paclitaxel
Deaths Number Affected:
0
Deaths Number At Risk:
None
Serious Number Affected:
9
Serious Number At Risk:
26
Other Number Affected:
26
Other Number At Risk:
26
Study:
NCT02551432
Results Section:
NCT02551432
Adverse Events Module:
NCT02551432